Skip to main content
Clinical Trials/ACTRN12617001401347
ACTRN12617001401347
Completed
未知

Probiotic supplementation in neonates with major gastrointestinal surgical conditions: A Pilot Randomized Double Blind Placebo Controlled Trial

Princess Margaret Hospital for Children0 sites61 target enrollmentOctober 4, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Major congenital gastrointestinal anomalies
Sponsor
Princess Margaret Hospital for Children
Enrollment
61
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 4, 2017
End Date
April 27, 2020
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Princess Margaret Hospital for Children

Eligibility Criteria

Inclusion Criteria

  • (1\) Neonates (\>\=35 weeks gestation) with the following major congenital gastrointestinal anomalies: Intestinal Atresia (duodenal, jejunal, ileal or colonic), Intestinal Malrotation, Tracheo\-Oesophageal fistula, Oesphageal atresia, Gastroschisis, Exompholos, Congenital Diaphragmatic Hernia, Meconium ileus or peritonitis requiring laparotomy, Hirschsprung Disease, Anal atresia, Impeforate anus, Short Bowel Syndrome, and any surgical condition needing the creation of small or large intestinal stoma (eg severe meconium ileus, micro\-colon).

Exclusion Criteria

  • (1\) Non gastrointestinal surgical conditions. (2\) Neonates born at \<35 weeks' gestation

Outcomes

Primary Outcomes

Not specified

Similar Trials